Intrasense S.A. | Small-cap | Healthcare

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 7.7M
Total Liabilities 6.0M
Shareholders Equity 1.7M
Debt to Equity 3.65

Cash Flow Metrics

Revenue & Profitability Trend

Intrasense S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i2.2M3.3M3.8M4.2M3.4M
Cost of Goods Sold i686.0K361.0K245.0K648.0K507.0K
Gross Profit i1.6M2.9M3.5M3.5M2.9M
Gross Margin % i69.5%89.1%93.5%84.5%85.3%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i125.0K84.0K126.0K1.1M711.0K
Other Operating Expenses i1.7M1.6M2.0M161.0K248.0K
Total Operating Expenses i1.8M1.7M2.1M1.2M959.0K
Operating Income i-5.6M-3.5M-3.4M-1.2M-519.0K
Operating Margin % i-249.5%-106.1%-89.0%-27.5%-15.1%
Non-Operating Items
Interest Income i50.0K50.0K3.0K-7.0K
Interest Expense i45.0K46.0K40.0K17.0K49.0K
Other Non-Operating Income-----
Pre-tax Income i-5.7M-3.6M-3.4M-1.2M-705.0K
Income Tax i-----
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-5.7M-3.6M-3.4M-1.2M-705.0K
Net Margin % i-251.7%-108.3%-90.2%-28.7%-20.5%
Key Metrics
EBITDA i-4.3M-2.7M-2.1M-571.0K70.0K
EPS (Basic) i--€0.07-€0.11-€0.04-€0.04
EPS (Diluted) i--€0.07-€0.11-€0.04-€0.04
Basic Shares Outstanding i-51334243313274142791334622924207
Diluted Shares Outstanding i-51334243313274142791334622924207

Income Statement Trend

Intrasense S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i930.0K4.6M1.4M4.8M2.6M
Short-term Investments i-----
Accounts Receivable i323.0K609.0K1.0M1.5M1.0M
Inventory i----125.0K
Other Current Assets1.0K-1.0K--96.0K
Total Current Assets i2.4M6.4M3.5M6.7M4.3M
Non-Current Assets
Property, Plant & Equipment i00000
Goodwill i4.6M3.3M2.2M1.2M1.2M
Intangible Assets i4.6M3.3M2.2M1.2M1.2M
Long-term Investments-----
Other Non-Current Assets-1.0K1.0K---1.0K
Total Non-Current Assets i5.3M4.1M3.0M2.1M2.1M
Total Assets i7.7M10.5M6.5M8.8M6.4M
Liabilities
Current Liabilities
Accounts Payable i526.0K410.0K735.0K440.0K276.0K
Short-term Debt i504.0K327.0K634.0K457.0K253.0K
Current Portion of Long-term Debt-----
Other Current Liabilities2.4M3.0K162.0K14.0K8.0K
Total Current Liabilities i5.0M1.8M2.8M2.1M2.0M
Non-Current Liabilities
Long-term Debt i901.0K1.2M1.4M1.5M2.0M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities-27.0K-1.0K-1.0K1.0K
Total Non-Current Liabilities i1.1M1.3M1.7M1.7M2.2M
Total Liabilities i6.0M3.2M4.5M3.8M4.2M
Equity
Common Stock i2.6M2.6M1.6M1.6M1.2M
Retained Earnings i-5.7M-3.6M-3.4M-1.2M-704.0K
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i1.7M7.3M2.0M5.0M2.2M
Key Metrics
Total Debt i1.4M1.5M2.1M1.9M2.3M
Working Capital i-2.6M4.5M699.0K4.6M2.3M

Balance Sheet Composition

Intrasense S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-5.7M-3.6M-3.4M-1.2M-704.0K
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i491.0K-59.0K-791.0K-524.0K-404.0K
Operating Cash Flow i-5.2M-3.4M-4.2M-1.7M-1.1M
Investing Activities
Capital Expenditures i-2.2M-1.9M-1.5M-554.0K-596.0K
Acquisitions i-----
Investment Purchases i-2.0K-1.0K-1.0K-1.0K0
Investment Sales i----45.0K
Investing Cash Flow i-2.2M-1.9M-1.5M-555.0K-551.0K
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i153.0K64.0K592.0K30.0K741.0K
Debt Repayment i-316.0K-649.0K-456.0K-355.0K-270.0K
Financing Cash Flow i2.3M8.1M137.0K3.7M2.8M
Free Cash Flow i-5.9M-5.0M-3.4M-1.5M-1.0M
Net Change in Cash i-5.0M2.7M-5.6M1.4M1.1M

Cash Flow Trend

Intrasense S.A Key Financial Ratios

Valuation Ratios

Forward P/E -5.68
Price to Book 9.16
Price to Sales 6.78
PEG Ratio -5.68

Profitability Ratios

Profit Margin -251.78%
Operating Margin -339.60%
Return on Equity -126.47%
Return on Assets -38.68%

Financial Health

Current Ratio 0.48
Debt to Equity 84.95
Beta -0.02

Per Share Data

EPS (TTM) -€0.11
Book Value per Share €0.03
Revenue per Share €0.04

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alins15.2M-9.16-126.47%-251.78%84.95
Equasens 772.6M16.533.3416.13%16.72%25.65
Cegedim S.A 143.2M92.860.54-4.95%-2.25%115.34
Abl Diagnostics 86.8M535.0011.514.00%4.86%34.10
Smaio S.A 36.9M16.304.98-29.15%-42.73%33.75
Ama Corp Plc 14.4M-5.72-176.91%-294.90%159.28

Financial data is updated regularly. All figures are in the company's reporting currency.